-
1
المؤلفون: Iacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, Theodore P Abraham, Ahmad Masri, Pablo Garcia-Pavia, Sara Saberi, Neal K Lakdawala, Matthew T Wheeler, Anjali Owens, Milos Kubanek, Wojciech Wojakowski, Morten K Jensen, Juan Gimeno-Blanes, Kia Afshar, Jonathan Myers, Sheila M Hegde, Scott D Solomon, Amy J Sehnert, David Zhang, Wanying Li, Mondira Bhattacharya, Jay M Edelberg, Cynthia Burstein Waldman, Steven J Lester, Andrew Wang, Carolyn Y Ho, Daniel Jacoby, Jozef Bartunek, Antoine Bondue, Emeline Van Craenenbroeck, David Zemanek, Morten Jensen, Jens Mogensen, Jens Jakob Thune, Philippe Charron, Albert Hagege, Olivier Lairez, Jean-Noël Trochu, Christoph Axthelm, Hans-Dirk Duengen, Norbert Frey, Veselin Mitrovic, Michael Preusch, Jeanette Schulz-Menger, Tim Seidler, Michael Arad, Majdi Halabi, Amos Katz, Daniel Monakier, Offir Paz, Samuel Viskin, Donna Zwas, Hans Peter Brunner-La Rocca, Michelle Michels, Dariusz Dudek, Zofia Oko-Sarnowska, Nuno Cardim, Helder Pereira, Pablo García Pavia, Juan Gimeno Blanes, Rafael Hidalgo Urbano, Luis Miguel Rincón Diaz, Perry Elliott, Zaheer Yousef, Theodore Abraham, Paulino Alvarez, Richard Bach, Richard Becker, Lubna Choudhury, David Fermin, John Jefferies, Christopher Kramer, Neal Lakdawala, Steven Lester, Ali Marian, Mathew Maurer, Sherif Nagueh, David Owens, Florian Rader, Mark Sherrid, Jamshid Shirani, John Symanski, Aslan Turer, Omar Wever-Pinzon, Matthew Wheeler, Timothy Wong, Mohamad Yamani
المساهمون: Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), RS: Carim - H02 Cardiomyopathy, MUMC+: MA Med Staf Spec Cardiologie (9), Cardiologie
المصدر: DDFV: Repositorio Institucional de la Universidad Francisco de Vitoria
Universidad Francisco de Vitoria
The Lancet
The Lancet, Elsevier, 2020, 396 (10253), pp.759-769. ⟨10.1016/S0140-6736(20)31792-X⟩
Lancet, 396(10253), 759-769. Elsevier Science
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Olivotto, I, Oreziak, A, Barriales-Villa, R, Abraham, T P, Masri, A, García Pavia, P, Saberi, S, Lakdawala, N K, Wheeler, M T, Owens, A, Kubanek, M, Wojakowski, W, Jensen, M K, Gimeno-Blanes, J, Afshar, K, Myers, J, Hegde, S M, Solomon, S D, Sehnert, A J, Zhang, D, Li, W, Bhattacharya, M, Edelberg, J M, Waldman, C B, Lester, S J, Wang, A, Ho, C Y, Jacoby, D & EXPLORER-HCM 2020, ' Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM) : a randomised, double-blind, placebo-controlled, phase 3 trial ', The Lancet, vol. 396, no. 10253, pp. 759-769 . https://doi.org/10.1016/S0140-6736(20)31792-Xمصطلحات موضوعية: medicine.medical_specialty, hypertrophic cardiomyopathy, mavacamten, LVOTO, [SDV]Life Sciences [q-bio], Cardiomyopathy, EXERCISE, 030204 cardiovascular system & hematology, Placebo, DIAGNOSIS, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Clinical endpoint, MANAGEMENT, Medicine, Ventricular outflow tract, 030212 general & internal medicine, OUTCOMES, business.industry, NATRIURETIC PEPTIDE, Hypertrophic cardiomyopathy, General Medicine, medicine.disease, Pathophysiology, 3. Good health, Clinical trial, Cardiology, business, TASK-FORCE